Effect of Best Practice Advisory on the administration of contraindicated medications to hospitalized patients with Parkinson’s disease and related disorders
Objective: To determine if a best practice advisory (BPA) reduced the orders and administration of contraindicated dopamine blocking agents (DBA) to hospitalized patients with Parkinson’s…Patients activation in people with Parkinson disease and its relation to personal factors
Objective: To identify individual factors associated with patient activation among people with Parkinson’s disease (PD). Background: The concept of patient activation captures subjective aspects of…A vicious cycle of karyopherin abnormalities in synucleinopathies
Objective: This study aims to investigate the role of karyopherin abnormalities in the onset and progression of synucleinopathies. Background: Despite differences in clinical manifestations, Parkinson’s…Electrophysiological correlates of the increase in rigidity with the Froment maneuver in Parkinson’s patients
Objective: To investigate the physiological basis underlying the increase of rigidity during co-innervation (Froment maneuver) in Parkinson´s disease (PD) patients and to probe whether this…Effects of cerebellar theta burst stimulation on working memory in Parkinson’s disease
Objective: This study aims to investigate the effects of cerebellar theta burst stimulation (TBS) on working memory (WM) performance in patients with Parkinson’s disease (PD)…Placebo response in Parkinson’s disease (PD) is predicted by expression levels of a specific brain network
Objective: To determine whether baseline expression levels for the previously validated sham surgery-related metabolic pattern (SSRP) can be used to predict the magnitude of the…Challenges in patient-physician communication during limited time appointments in Parkinson’s disease
Objective: Our aim is to analyze challenges in patient-physician communication during limited time appointments in Parkinson’s disease (PD). Background: Due to limited number of movement…Parkinson’s Progression Markers Initiative (PPMI) prioritizes enrollment of individuals from diverse and underrepresented populations
Objective: To describe the goals and Year 1 initiatives of PPMI Diversity, Equity, and Inclusion (DEI) taskforce Background: Clinical trials under-enroll people with Parkinson’s disease…Deep brain stimulation impacts functional brain connectivity in Parkinson’s disease.
Objective: Deep-brain stimulation (DBS) became a successful method to treat Parkinson’s disease (PD), particularly with stimulating the subthalamic nucleus (STN-DBS), although the precise mechanisms mediating…Efficacy of a four-strain probiotic on gut dysbiosis, motor and non-motor symptoms in Parkinson`s disease: a multicentre randomised controlled trial
Objective: To evaluate the effect of a four-strain probiotic (Lacticaseibacillus rhamnosus, Enterococcus faecium, Lactobacillus acidophilus, Lactiplantibacillus plantarum) on gut microbiota composition, motor and non-motor symptoms…
- « Previous Page
- 1
- …
- 243
- 244
- 245
- 246
- 247
- …
- 436
- Next Page »